Pfizer/BioNTech say 3 COVID shots generate good response in under-5s
Pfizer/BioNTech say 3 COVID shots generate good response in under-5s
Source: bdnews24.com
Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer/BioNTech say 3 COVID shots generate good response in under-5s
Pfizer conducted trials on the vaccine's effects on the age group.
Pfizer shots for 5- to 11-year-olds opened in November, but only about 30% of that age group have gotten the initial two doses.
Pfizer conducted trials on the vaccine's effects on the age group.
Pfizer conducted trials on the vaccine's effects on the age group.